Trinity Biotech | TRIB - Cost Of Sales

Stock Price
0.80
Daily Change
0.09 13.06%
Monthly
5.74%
Yearly
-3.47%
Q1 Forecast
0.79

Trinity Biotech reported $7.84M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Abbott USD 4.92B 535M Dec/2025
Bayer EUR 4.31B 57M Sep/2025
Bio-Rad Laboratories USD 306.3M 31.5M Jun/2025
EDAP TMS EUR 9.22M 1.36M Jun/2025
J&J USD 7.97B 689M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Siemens EUR 13.32B 1.48B Sep/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
Tosoh JPY 190.27B 3.82B Dec/2025
Trinity Biotech USD 7.84M 3.14M Sep/2025
Veracyte USD 41.21M 196K Sep/2025